Clinical research for curing ankylosing spondylitis through combining etanercept, thalidomide and sulfasalazine

Journal Title: Pakistan Journal of Pharmaceutical Sciences - Year 2015, Vol 28, Issue 1

Abstract

 This article is to explore the curative effect of treating ankylosing spondylitis (AS) through combining etanercept, thalidomide and sulfasalazine. Sixty-two patients with AS were divided into 3 groups: experimental group A is treated by etanercept + thalidomide + sulfasalazine for 1 year (n=22); control group B was treated with etanercept; control group C was treated with thalidomide + sulfasalazine for 1 year (n=20). In 1st, 3rd, 6th, 12th month after the treatment, ASAS20 and ASAS50 were obtained through Bath ankylosing spondylitis disease activity index (BASDAI), Bath ankylosing spondylitis functional index (BASFI), erythrocyte sedimentation rate (ESR), C react protein (CRP) and then curative effect was analyzed. In 1 and 3 months after the treatment, each indicator had downtrend, and ASAS20 of experimental group and etanercept control group reached 100%; ASAS50 increased compared with the first months’ treatment; although ASAS20 and ASAS50 in thalidomide control group was smaller, they increased; in 6 and 12 months after the treatment, ASAS20 improvement ratio in group A still remained on 100%, ASA50 improvement ratio increased; recurrence rate of group B increased; ASA20 and ASA50 had a continuous and significant increase, but its their was less than group A. This study proved that, the effect of curing AS combining etanercept, thalidomide and sulfasalazine is better, therefore, it is a high-feasible treatment approach.

Authors and Affiliations

Peng Xiao , Changhe Pang , Xu Zhu , Xuejian Wu

Keywords

Related Articles

Human Pappilomavirus (HPV) induced cancers and prevention by immunization

Incidences of different types of cancer are increasing in Pakistan, among which cancer of Cervix and Respiratory pappilomatosis are of great concern because of their association with human Pappilomavirus (HPV). Cervical...

 Development and bioevaluation of 99mTc(CO)3-labeled (1-azido-1-deoxy-β-D-glucopyranoside) complex as a potential tumor-seeking agent

 The 1,2,3-triazole-containing (1-azido-1-deoxy-β-D-glucopyranoside) complex was synthesized using click chemistry approach and evaluated its potential as a tumor-seeking agent. In the present study, 99mTc-tricarbon...

 History of Pu’er Tea and comparative study for the effect of its various extracts on lipid-lowering diet

 Pu’er Tea is a kind of traditional historical famous tea which gains its name for native government jurisdiction in Pu’er (now Xishuangbanna in Yunnan, Pu’er city etc), and takes Pu’er (now Ninger county of Pu'er c...

 Ultra structural study of the rat cheek epithelium treated with Neem extract

 The purpose of this study was to investigate the effects of neem extract (Azadirachta indica A. Juss) on the ultrastructure of the rat oral epithelium, because neem extract has been added in the tooth paste as an a...

 Antimicrobial potentials and phytochemical analysis of desert cotton (A. Javanica) and flax (L. Ustitatissimum)

 The present study reveals antimicrobial potentials and phytochemical analysis of A. javanica and L. ustitatissimum. Phytochemical analysis indicated that the tested plants contained a substantial amount of flavonoi...

Download PDF file
  • EP ID EP127122
  • DOI -
  • Views 124
  • Downloads 0

How To Cite

Peng Xiao, Changhe Pang, Xu Zhu, Xuejian Wu (2015).  Clinical research for curing ankylosing spondylitis through combining etanercept, thalidomide and sulfasalazine. Pakistan Journal of Pharmaceutical Sciences, 28(1), 359-362. https://europub.co.uk./articles/-A-127122